Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVANT: Bevacizumab in Adjuvant Colon Cancer
NCT00112918Phase 3Completed
- Sponsor
- Roche
- Start
- Dec 2004
- Primary completion
- Jun 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in colon carcinoma, sponsored by Roche. Started Dec 2004; status: completed.
02
Drugs
bevacizumab
03
Conditions
colon carcinoma
Beyond the preview
Go deeper on NCT00112918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00112918.